Schizophrenia/Psychosis

Artificial intelligence and natural language processing provide powerful new tools to measure thought disorder and negative symptoms in schizophrenia.

How is “disease” defined? A popular criticism of psychiatry gets debunked.

A growing body of scientific literature makes the case.

An extended release, ultra-long acting antipsychotic takes another step forward in the approval process.

New research may help better understand psychosis etiology as well as provide potential biomarkers for psychosis.

Cannabis has been heralded as a treatment for many conditions, but what about its psychiatric risks?

A recent study dives into the data.

Simple but powerful strategies for drawing on patients’ existing character strengths and long-term goals.

Being unable to experience pleasure and having difficulty imagining future enjoyment are different problems—and may require different treatments.

This combination treatment of olanzapine and samidorphan caused significantly less weight gain in patients with schizophrenia and bipolar I disorder.

Sleep problems are understudied, underdiagnosed, and undertreated.

What do we know about TD? What is on the horizon? Take the quiz to learn more.

There is debate whether schizoaffective disorder is a separate illness or is part of the continuum of schizophrenia and mood disorder spectrum.

In this conversation, a former APA president discusses mystical and meditative experiences, reconciling psychoanalysis and neuroscience, and tensions surrounding the medical model.

This treatment for agitation associated with schizophrenia and bipolar disorder is moving up the FDA ladder…

Because schizophrenia is associated with increased inflammation, studies on the effects of anti-inflammatory statins are warranted.

What are the implications of maternal mental health not only for mothers, but also for children, families, and society as a whole?

Two posters presented at the APA virtual meeting demonstrated long-acting injectable positive results, costs savings, and increased telehealth for patients with schizophrenia.

Data presented at the 2021 APA Virtual Annual Meeting show promise for treating schizophrenia.

The sexual side effects of psychiatric medications are troubling enough that some patients consider treatment cessation. The authors review 5 strategies for managing sexual dysfunction.

There is evidence for overlapping risk factors and symptomatology between ADHD and psychotic disorders. New research investigates the association between ADHD during childhood and the subsequent risk of developing a psychotic disorder.

Ronald W Pies, MD, considers the evidence from pathology textbooks—and answers the critics.

A lawyer discusses how the legal system treats (and mistreats) those with mental illnesses.

A new risperidone capsule for the treatment of schizophrenia sees positive phase 2 study results.